Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs

BACKGROUND: There is a lack of clinically available predictive models for patients with epidermal growth factor receptor (EGFR) mutation positive, advanced non–small cell lung cancer (NSCLC) treated with EGFR‐tyrosine kinase inhibitors (TKIs). METHODS: The clinical data of patients at the Cancer Hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xinyang, Bai, Hua, Wang, Zhijie, Daun, Jianchun, Liu, Zheng, Xu, Jiachen, Chang, Geyun, Zhu, Yixiang, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058307/
https://www.ncbi.nlm.nih.gov/pubmed/35347870
http://dx.doi.org/10.1111/1759-7714.14380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058307/
https://www.ncbi.nlm.nih.gov/pubmed/35347870
http://dx.doi.org/10.1111/1759-7714.14380

Ejemplares similares